These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3949012)

  • 1. Formation of metabolites of [Arg8]vasopressin (AVP) by brain peptidases. Conversion of the intermediate [Cyt6]AVP-(3-9).
    Wang XC; Burbach JP
    FEBS Lett; 1986 Mar; 197(1-2):164-8. PubMed ID: 3949012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolytic conversion of arginine-vasopressin and oxytocin by brain synaptic membranes. Characterization of formed peptides and mechanisms of proteolysis.
    Burbach JP; Lebouille JL
    J Biol Chem; 1983 Feb; 258(3):1487-94. PubMed ID: 6337140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolytic conversion of oxytocin by brain synaptic membranes: role of aminopeptidases and endopeptidases.
    Stancampiano R; Melis MR; Argiolas A
    Peptides; 1991; 12(5):1119-25. PubMed ID: 1800950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure activity relationship studies with C-terminal fragments of vasopressin and oxytocin on avoidance behaviors of rats.
    de Wied D; Gaffori O; Burbach JP; Kovács GL; van Ree JM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):268-74. PubMed ID: 3572787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No. 302, a newly synthesized [pGlu4,Cyt6]AVP(4-9) analogue, prevents the disruption of avoidance behavior.
    Hirate K; Hirano M; Nakajima Y; Hiyama A; Maeda O; Asakura W
    Behav Brain Res; 1997 Feb; 83(1-2):205-8. PubMed ID: 9062685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vasopressin, oxytocin and peptides derived from these hormones on field potential induced in lateral septum of rats by stimulation of the fimbria fornix.
    Urban IJ; De Wied D
    Neuropeptides; 1986 Jan; 7(1):41-9. PubMed ID: 3951680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin anti-idiotypic antibody staining in the rat brain: colocalization with [35S] [pGlu4, Cyt6]AVP(4-9) binding sites.
    Jurzak M; Fahrenholz F; Gerstberger R
    J Neuroendocrinol; 1993 Oct; 5(5):523-31. PubMed ID: 8680420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of circulating vasopressin uptake by choroid plexus.
    Zlokovic BV; Segal MB; McComb JG; Hyman S; Weiss MH; Davson H
    Am J Physiol; 1991 Feb; 260(2 Pt 2):F216-24. PubMed ID: 1899978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of arginine vasopressin, [pGlu4,Cyt6]arginine vasopressin-(4-9) and nerve growth factor on maintenance of functional tolerance to ethanol in mice.
    Szabó G; Tabakoff B; Hoffman PL
    Eur J Pharmacol; 1991 Jun; 199(1):131-4. PubMed ID: 1909962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of arginine vasopressin on protein phosphorylation in rat hippocampal synaptic membranes.
    Hinko A; Pearlmutter AF
    J Neurosci Res; 1987; 17(1):71-9. PubMed ID: 3033258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor?
    de Wied D; Elands J; Kovács G
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1494-8. PubMed ID: 1847526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemistry of vasopressin fragments.
    Burbach JP; Schoots O; Hernando F
    Prog Brain Res; 1998; 119():127-36. PubMed ID: 10074785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxytocin biotransformation in the rat limbic brain: characterization of peptidase activities and significance in the formation of oxytocin fragments.
    Burbach JP; De Kloet ER; De Wied D
    Brain Res; 1980 Dec; 202(2):401-14. PubMed ID: 7002262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term facilitation of social recognition in rats by vasopressin related peptides: a structure-activity study.
    Popik P; Van Ree JM
    Life Sci; 1992; 50(8):567-72. PubMed ID: 1736027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of vasopressin-converting aminopeptidase activity and vasopressin metabolites.
    Burbach JP; Liu B
    Methods Enzymol; 1989; 168():385-97. PubMed ID: 2657337
    [No Abstract]   [Full Text] [Related]  

  • 16. Facilitation of avoidance behavior by vasopressin fragments microinjected into limbic-midbrain structures.
    Kovács GL; Veldhuis HD; Versteeg DH; De Wied D
    Brain Res; 1986 Apr; 371(1):17-24. PubMed ID: 3708341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alpha1-adrenergic receptor blockade by doxazosin on renin-angiotensin system-regulating aminopeptidase and vasopressin-degrading activities in male and female rat thalamus.
    de la Chica-Rodríguez S; Cortés-Denia P; Ramírez-Expósito MJ; Martínez-Martos JM
    Horm Metab Res; 2007 Nov; 39(11):813-7. PubMed ID: 17992636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin fragment, AVP-(4-8), improves long-term and short-term memory in the hole board search task.
    Vawter MP; De Wied D; Van Ree JM
    Neuropeptides; 1997 Oct; 31(5):489-94. PubMed ID: 9413027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of beta-endorphin2-9 on arginine-8-vasopressin and oxytocin levels in hypothalamic and limbic brain regions.
    Laczi F; Vecsernyés M; Kovács GL; Szabó G; Janáky T; Telegdy G; Lásló FA
    Brain Res; 1987 Feb; 403(1):155-7. PubMed ID: 3828809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin neuropeptides and acquisition of heroin and cocaine self-administration in rats.
    van Ree JM; Burbach-Bloemarts EM; Wallace M
    Life Sci; 1988; 42(10):1091-9. PubMed ID: 3347140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.